ACCESS Newswire

Armor

6.5.2024 17:03:47 CEST | ACCESS Newswire | Press release

Share
Armor Unveils a Disruptive Approach to Managed Detection and Response

Strengthening enterprise resiliency against evolving threats through the new Armor Managed Detection and Response (MDR) service.

DALLAS, TX / ACCESSWIRE / May 6, 2024 / Armor, a leading provider of cybersecurity and compliance solutions, is thrilled to announce the launch of its latest offering Armor Managed Detection and Response (MDR), ushering in a different era for MDR through adaptive threat management and defense.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Logo for Armor

Enterprises are challenged by an array of evolving cyber threats, and yet conventional MDR strategies fixate on detection and response, without an integrated risk management approach. Armor MDR addresses this critical gap by integrating with industry-leading security platforms for unparalleled threat context - enabling high confidence triage, response and defense optimization.

Our partnership with Microsoft in particular, supercharges solutions like Microsoft Defender XDR and Microsoft Sentinel to fully harness their power for adaptive threat prevention, detection and response.

"In view of the modern sophistication of cyber threats, and current state of cybersecurity, adaptivity isn't just an advantage; it's the very foundation of digital defense," said Dennis Chung, Chief Security Officer, Microsoft. "Novel approaches like Armor MDR empowers enterprises to out-maneuver advanced threats through proactive and adaptable defenses."

Chris Drake, Founder and CEO of Armor, said, "Attempting to tackle emerging cybersecurity threats with traditional Threat Detection, Investigation and Response (TDIR) is a clumsy approach that likens playing whack-a-mole. To truly raise defensibility requires strategic and continuous improvements at the source - that's what Armor has launched."

The Armor MDR service is grounded in these distinctive core principles:

Contextual Threat Prioritization and Response: By developing a unique enterprise risk profile per customer, this rich context empowers Armor MDR to determine the pertinence and impact of potential security threats more effectively and swiftly neutralize potential threats before they escalate.

Analytics-Powered Security Strategies: Outcome-driven metrics are used to inform and uncover security improvements. By harnessing the power of artificial intelligence and machine learning, Armor's MDR service captures opportunities to accelerate incident response, leverage automation to enhance the TDIR process, and proactively improve security configurations.

Continuously Raising Defensibility: The insights from security incident triage and remediation are integrated into a feedback loop to update relevant security configurations, thereby significantly improving enterprise risk resiliency and threat prevention.

The service is now available to organizations seeking to fortify their cyber defenses against the unyielding tide of cyber threats, and industry partners looking to provide enhanced security outcomes for their customers. For more information about Armor and the Armor MDR service, visit www.armor.com/solutions/armor-mdr.

----

ABOUT ARMOR

Armor, a global cybersecurity leader, provides comprehensive managed detection and response (MDR) and compliant cloud solutions. By combining advanced technology with expert services, Armor protects businesses from cyber threats, mitigates their risk, and ensures regulatory compliance. Dedicated to innovation and excellence, Armor is trusted by thousands of customers worldwide. The company is headquartered in Dallas, Texas, and has offices in the United States, United Kingdom, and Singapore.

For more information, visit www.armor.com.

Contact Information

Armor PR
Armor Corporate Communications
press@armor.com
877 262 3473

Eloise Garrett
Director, The Right Agency
eloise@rightagency.co.uk
+44 7976048542

SOURCE: Armor

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio9.2.2026 23:00:00 CET | Press release

All amounts in US dollars unless otherwise stated. VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF)(FSE:Y2V) ("RE Royalties" or the "Company") is pleased to announce a further USD $800,000 investment toward the purchase of royalties on two portfolios of distributed generation ("DG") solar projects located throughout the United States being developed by Solaris Energy Inc. ("Solaris"). The Royalty Purchase for Portfolio 1 totals USD $4.8 million, of which USD $3 million was funded at closing, as announced on January 7, 2026. The Company expects to fund the remaining USD $1 million by Q2 2026, subject to the satisfaction of applicable conditions. The Royalty Purchase for Portfolio 2 is subject to the completion of due diligence to the satisfaction of the Company, other customary closing conditions, and is expected to occur later in the year, bringing the total portfolio level royalty investment to USD $9 million. The Royalty Rate will be adju

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release

NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av

Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release

Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye